Nuclear restriction of HIV-1 infection by SUN1.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
27 09 2021
Historique:
received: 02 04 2021
accepted: 02 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 12 2021
Statut: epublish

Résumé

Overexpression of the human Sad-1-Unc-84 homology protein 2 (SUN2) blocks HIV-1 infection in a capsid-dependent manner. In agreement, we showed that overexpression of SUN1 (Sad1 and UNC-84a) also blocks HIV-1 infection in a capsid-dependent manner. SUN2 and the related protein SUN1 are transmembrane proteins located in the inner membrane of the nuclear envelope. The N-terminal domains of SUN1/2 localizes to the nucleoplasm while the C-terminal domains are localized in the nuclear lamina. Because the N-terminal domains of SUN1/2 are located in the nucleoplasm, we hypothesized that SUN1/2 might be interacting with the HIV-1 replication complex in the nucleus leading to HIV-1 inhibition. Our results demonstrated that SUN1/2 interacts with the HIV-1 capsid, and in agreement with our hypothesis, the use of N-terminal deletion mutants showed that SUN1/2 proteins bind to the viral capsid by using its N-terminal domain. SUN1/2 deletion mutants correlated restriction of HIV-1 with capsid binding. Interestingly, the ability of SUN1/2 to restrict HIV-1 also correlated with perinuclear localization of these proteins. In agreement with the notion that SUN proteins interact with the HIV-1 capsid in the nucleus, we found that restriction of HIV-1 by overexpression of SUN proteins do not block the entry of the HIV-1 core into the nucleus. Our results showed that HIV-1 restriction is mediated by the interaction of SUN1/2N-terminal domains with the HIV-1 core in the nuclear compartment.

Identifiants

pubmed: 34580332
doi: 10.1038/s41598-021-98541-4
pii: 10.1038/s41598-021-98541-4
pmc: PMC8476499
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Membrane Proteins 0
Microtubule-Associated Proteins 0
Nuclear Proteins 0
SUN1 protein, human 0
SUN2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

19128

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI087390
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM086262
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Nature. 2011 Apr 28;472(7344):481-5
pubmed: 21478870
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15910-5
pubmed: 20733078
PLoS Pathog. 2012;8(8):e1002896
pubmed: 22956906
Cell Host Microbe. 2010 Mar 18;7(3):221-33
pubmed: 20227665
J Virol. 2002 Dec;76(24):12866-76
pubmed: 12438612
Curr Opin Microbiol. 2006 Aug;9(4):404-8
pubmed: 16815734
J Virol. 2012 Apr;86(7):3851-60
pubmed: 22301135
Curr Biol. 2008 Aug 26;18(16):R710-3
pubmed: 18727908
PLoS One. 2010 Dec 14;5(12):e15620
pubmed: 21179483
Mol Biol Int. 2012;2012:868597
pubmed: 22888429
PLoS Pathog. 2011 Mar;7(3):e1001313
pubmed: 21423673
Retrovirology. 2013 Feb 15;10:20
pubmed: 23414560
J Virol. 2016 Mar 28;90(8):4199-4214
pubmed: 26865710
EMBO J. 2001 Mar 15;20(6):1300-9
pubmed: 11250896
Curr Biol. 2008 Aug 26;18(16):1192-202
pubmed: 18722123
PLoS Pathog. 2013;9(10):e1003693
pubmed: 24130490
Cell Death Dis. 2013 Oct 31;4:e888
pubmed: 24176846
J Biol Chem. 2004 Jun 11;279(24):25805-12
pubmed: 15082709
J Virol. 2017 Feb 28;91(6):
pubmed: 28077629
J Virol. 2018 Jun 13;92(13):
pubmed: 29643244
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E1054-63
pubmed: 26858452
PLoS One. 2012;7(9):e46037
pubmed: 23049930
Science. 1999 Jan 1;283(5398):80-3
pubmed: 9872746
J Virol. 2012 May;86(10):5931-6
pubmed: 22398280
Virology. 2008 Sep 1;378(2):233-42
pubmed: 18586294
Nat Rev Mol Cell Biol. 2006 Oct;7(10):782-8
pubmed: 16926857
Virology. 2014 Jul;460-461:34-44
pubmed: 25010268
J Virol. 2017 Sep 12;91(19):
pubmed: 28747499
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5486-5493
pubmed: 32094182
Cell Rep. 2020 Sep 29;32(13):108201
pubmed: 32997983
Nat Microbiol. 2020 Sep;5(9):1088-1095
pubmed: 32483230
Virology. 2013 May 25;440(1):8-18
pubmed: 23523133
PLoS Pathog. 2011 Dec;7(12):e1002439
pubmed: 22174692
J Virol. 2013 Oct;87(19):10587-97
pubmed: 23885082
J Virol. 2011 Sep;85(17):8725-37
pubmed: 21734049

Auteurs

Mirjana Persaud (M)

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

Anastasia Selyutina (A)

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

Cindy Buffone (C)

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

Silvana Opp (S)

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

Daniel A Donahue (DA)

Department of Virology, Virus & Immunity Unit, Institut Pasteur, Paris, France.

Oliver Schwartz (O)

Department of Virology, Virus & Immunity Unit, Institut Pasteur, Paris, France.

Felipe Diaz-Griffero (F)

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA. Felipe.Diaz-Griffero@einsteinmed.org.
Albert Einstein College of Medicine, 1301 Morris Park - Price Center 501, New York, NY, 10461, USA. Felipe.Diaz-Griffero@einsteinmed.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH